Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heimo Lagler

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Pathogens (Basel, Switzerland)|February 26, 2022
Evaluation of Eosinophilic Cationic Protein as a Marker of Alveolar and Cystic EchinococcosisJulian Frederic Hotz, Klaus Kaczirek, Stefan Stremitzer, et al.
Neurology and Therapy|June 9, 2025
Dysphagia Management is Associated with Reduced Mortality in Patients with Moderate to Severe Acute Ischemic StrokeJulian Frederic Hotz, Lisa Kaindl, Lisa Schneider, et al.
Antimicrobial Agents and Chemotherapy|May 30, 2019
Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Study of the Penetration of a Monoclonal Antibody Combination (ASN100) Targeting <i>Staphylococcus aureus</i> Cytotoxins in the Lung Epithelial Lining Fluid of Healthy VolunteersZoltan Magyarics, Fraser Leslie, Johann Bartko, et al.
BMC Infectious Diseases|September 2, 2024
Unraveling novel mutation patterns and morphological variations in two dalbavancin-resistant MRSA strains in Austria using whole genome sequencing and transmission electron microscopyJulian Frederic Hotz, Moritz Staudacher, Katharina Schefberger, et al.
European Journal of Clinical Pharmacology|May 10, 2021
A phase I study assessing the safety, tolerability, immunogenicity, and low-density lipoprotein cholesterol-lowering activity of immunotherapeutics targeting PCSK9Markus Zeitlinger, Martin Bauer, Roman Reindl-Schwaighofer, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
Ergosterol-depleted clinical isolates of <i>Nakaseomyces glabratus</i> can develop multi-drug resistance without apparent fitness and virulence defectsAlexander M Aldejohann, Nadja Thielemann, Aina Martinez Zurita, et al.
The Lancet. Infectious Diseases|June 26, 2020
Burden of disease in Gabon caused by loiasis: a cross-sectional surveyLuzia Veletzky, Jennifer Hergeth, Daniel R Stelzl, et al.
Mbio|May 20, 2026
Ergosterol-depleted clinical isolates of <i>Nakaseomyces glabratus</i> can develop multi-drug resistance without severe fitness defects or attenuated virulence in an invertebrate infection modelAlexander M Aldejohann, Nadja Thielemann, Aina Martinez Zurita, et al.
International Journal of Environmental Research and Public Health|April 30, 2021
A Longitudinal Seroprevalence Study Evaluating Infection Control and Prevention Strategies at a Large Tertiary Care Center with Low COVID-19 IncidenceLorenz Schubert, Robert Strassl, Heinz Burgmann, et al.
BMJ Open|November 24, 2021
Evaluation of the safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in HIV-infected pregnant women: protocol of a multicentre, two-arm, randomised, placebo-controlled, superiority clinical trial (MAMAH project)Raquel González, Tacilta Nhampossa, Ghyslain Mombo-Ngoma, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Pathogens (Basel, Switzerland)|February 26, 2022
Evaluation of Eosinophilic Cationic Protein as a Marker of Alveolar and Cystic EchinococcosisJulian Frederic Hotz, Klaus Kaczirek, Stefan Stremitzer, et al.
Neurology and Therapy|June 9, 2025
Dysphagia Management is Associated with Reduced Mortality in Patients with Moderate to Severe Acute Ischemic StrokeJulian Frederic Hotz, Lisa Kaindl, Lisa Schneider, et al.
Antimicrobial Agents and Chemotherapy|May 30, 2019
Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Study of the Penetration of a Monoclonal Antibody Combination (ASN100) Targeting <i>Staphylococcus aureus</i> Cytotoxins in the Lung Epithelial Lining Fluid of Healthy VolunteersZoltan Magyarics, Fraser Leslie, Johann Bartko, et al.
BMC Infectious Diseases|September 2, 2024
Unraveling novel mutation patterns and morphological variations in two dalbavancin-resistant MRSA strains in Austria using whole genome sequencing and transmission electron microscopyJulian Frederic Hotz, Moritz Staudacher, Katharina Schefberger, et al.
European Journal of Clinical Pharmacology|May 10, 2021
A phase I study assessing the safety, tolerability, immunogenicity, and low-density lipoprotein cholesterol-lowering activity of immunotherapeutics targeting PCSK9Markus Zeitlinger, Martin Bauer, Roman Reindl-Schwaighofer, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
Ergosterol-depleted clinical isolates of <i>Nakaseomyces glabratus</i> can develop multi-drug resistance without apparent fitness and virulence defectsAlexander M Aldejohann, Nadja Thielemann, Aina Martinez Zurita, et al.
The Lancet. Infectious Diseases|June 26, 2020
Burden of disease in Gabon caused by loiasis: a cross-sectional surveyLuzia Veletzky, Jennifer Hergeth, Daniel R Stelzl, et al.
Mbio|May 20, 2026
Ergosterol-depleted clinical isolates of <i>Nakaseomyces glabratus</i> can develop multi-drug resistance without severe fitness defects or attenuated virulence in an invertebrate infection modelAlexander M Aldejohann, Nadja Thielemann, Aina Martinez Zurita, et al.
International Journal of Environmental Research and Public Health|April 30, 2021
A Longitudinal Seroprevalence Study Evaluating Infection Control and Prevention Strategies at a Large Tertiary Care Center with Low COVID-19 IncidenceLorenz Schubert, Robert Strassl, Heinz Burgmann, et al.
BMJ Open|November 24, 2021
Evaluation of the safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in HIV-infected pregnant women: protocol of a multicentre, two-arm, randomised, placebo-controlled, superiority clinical trial (MAMAH project)Raquel González, Tacilta Nhampossa, Ghyslain Mombo-Ngoma, et al.
Pageof 8